C18 steroid with androgenic and anabolic properties. It is generally prepared from alkyl ethers of estradiol to resemble testosterone but less one carbon at the 19 position. It is a... It is a schedule III drug in the U.S.
- Mechanism
- Curator reviewed
Nandrolone is an androgen receptor agonist. The drug bound to the receptor complexes which allows it to enter the nucleus and bind directly to specific nucleotide sequences of the chromosomal DNA. The areas of binding are called hormone response elements (HREs), and influence transcriptional activity of certain genes, producing the androgen effects.
- Primary indication
- For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner's syndrome.Curator reviewed
- Formula / weight
- C27H34O3 · 406.5571 g/mol (avg)
- Also known as
- 19NTPP · Nadrolone phenylpropionate · Nandrolon phenylpropionate · Nandrolone phenylpionate · Nandrolone phenylpropionate
- Code names
- NSC-23162
Resolves to
UBWXUGDQUBIEIZ-QNTYDACNSA-NSMILES[H][C@@]12CC[C@H](OC(=O)CCC3=CC=CC=C3)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H]What you can answer from here — as of September 23, 2026
Which drugs share a target with Nandrolone phenpropionate, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account